ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Neurology

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,438Medicare Part D Prescriptions Filled, Including Refills

Rank: 5 out of 106

$826K Total Retail Price of All Prescriptions

Rank: 16 out of 106

634 Patients Receiving at Least One Drug in Part D
65%Patients 65 Years and Older
55% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 634 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

11% of this provider’s 634 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

5% of this provider’s 4,214 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 3%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$111 was the average price of a prescription from this provider, compared to $175 among peers.

Prescriptions per Patient

12 is the average number of prescriptions (including refills) per patient, compared to an average of 11.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
GABAPENTIN 513 343 1 2
HYDROCODONE-ACETAMINOPHEN 347 135 S3 2 1
TOPIRAMATE 295 78 3 6
DONEPEZIL HCL 275 248 4 4
NAMENDA 271 255 5 7
LEVETIRACETAM 266 117 6 3
LAMOTRIGINE 224 89 7 10
BACLOFEN 221 105 8 13
DIPYRIDAMOLE 178 143 R 9 94
OXCARBAZEPINE 171 66 10 29
LYRICA 169 77 11 8
DIVALPROEX SODIUM ER 156 96 12 15
CYMBALTA 150 69 13 17
VIMPAT 143 24 14 19
PRIMIDONE 143 109 14 9
CLOPIDOGREL 130 108 16 33
CARBIDOPA-LEVODOPA 126 106 17 5
TRAZODONE HCL 108 54 18 24
NORTRIPTYLINE HCL 96 49 19 40
SIMVASTATIN 95 69 20 64
PRAMIPEXOLE DIHYDROCHLORIDE 84 37 21 21
AGGRENOX 84 69 21 55
CITALOPRAM HBR 82 47 23 16
PLAVIX 82 69 23 44
AMITRIPTYLINE HCL 82 55 R 23 14
DIVALPROEX SODIUM 76 61 26 37
MELOXICAM 75 52 27 36
PROPRANOLOL HCL 73 37 28 34
TRAMADOL HCL 69 22 29 25
ZONISAMIDE 68 16 30 28
CARISOPRODOL 67 12 R 31 22
MIRTAZAPINE 65 49 32 50
DICLOFENAC SODIUM 65 34 32 87
SERTRALINE HCL 62 44 34 32
CYCLOBENZAPRINE HCL 59 0 R 35 26
AZILECT 58 48 36 56
AMPHETAMINE SALT COMBO 54 0 S2 37 53
TIZANIDINE HCL 52 0 38 11
EXELON 51 51 39 31
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 28, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.